Tert-butyl 4-(4-bromophenyl)-2-(2,2-dichloroethenyl)-4-hydroxy-6-oxocyclohexane-1-carboxylate | 1382489-57-7

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: Tert-butyl 4-(4-bromophenyl)-2-(2,2-dichloroethenyl)-4-hydroxy-6-oxocyclohexane-1-carboxylate
• CAS: 1382489-57-7
• 化学式: C₁₉H₂₁BrCl₂O₄
• 分子量: 464.183
• InChiKey: RIPVUFLCXZEIFS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  26
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  63.6
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• [EN] ACTIVATORS OF CYLINDRICAL PROTEASES<br/>[FR] ACTIVATEURS DES PROTÉASES CYLINDRIQUES
  申请人：UNIV TORONTO

  公开号：WO2012079164A1

  公开（公告）日：2012-06-21

  The present invention is directed to activators of cylindrical proteases ("ACPs"), particularly ClpP, and the role thereof in the diagnosis and treatment of bacterial infections. A number of ACPs were identified that activate caseinolytic protease P ("ClpP"), which independently can only degrade small peptides. In the presence of ACPs, ClpP may be activated to allow it to degrade larger proteins, hence, abolishing the specificity arising from the ATP-dependent chaperones. Members of the ACPs were found to have bactericidal activity. As such, ACPs represent a new classes of compounds that can activate ClpP and that can be developed as potential novel antibiotics.

  本发明涉及圆柱形蛋白酶（“ACPs”）的激活剂，特别是ClpP，以及其在细菌感染的诊断和治疗中的作用。已经确定了许多激活酪蛋白酶P（“ClpP”）的ACP，独立地只能降解小肽。在存在ACP的情况下，ClpP可以被激活，使其能够降解更大的蛋白质，从而消除了ATP依赖的分子伴侣引起的特异性。发现了ACP成员具有杀菌活性。因此，ACP代表了一类新的化合物，可以激活ClpP，并可以作为潜在的新型抗生素开发。